Published Jan 1, 2020
#22 – Tom Dayspring Part III of V: reverse cholesterol transport, CETP inhibitors, & apolipoproteins
Dive into the intricate world of cholesterol transport and HDL functionality as Thomas Dayspring and Peter Attia dissect the latest research on reverse cholesterol transport, the dynamic role of HDL, and the complexities and clinical impacts of CETP inhibitors in lipid modulation.
